Some visit links earn us a commission.

Lowest compounded tirzepatide drug price in Nevada 2026: $69 a month, plus yearly membership

By John Samaras, price analyst · Prices checked Nov 16, 2026

Compounded tirzepatide, a pharmacy-made version that is not Zepbound or Mounjaro, ships to Nevada from $69 a month at Collective, plus a yearly membership, the lowest of the programs we track, read on November 16, 2026. Nevada Medicaid does not cover Zepbound for weight loss.

Paying cash for compounded tirzepatide in Nevada

Eden logo

Weight loss or money back Eden

compounded tirzepatide
$129/mo

Includes medication, provider review and shipping

Ships to Nevada. Same price at every dose.

Collective logo

Lowest monthly drug price Collective

compounded tirzepatide
$69/mo

Ships to Nevada. Same price at every dose.

Some links earn us a commission.

Who ships compounded tirzepatide to Nevada

  1. Collective: $69 a month
  2. Eden: $129 a month
  3. CoreAge Rx: $129 a month
  4. Embody: $129 a month
  5. SnagRx: $149 a month

Every program on our compounded tirzepatide chart ships to Nevada. The full chart has every price.

Does Nevada Medicaid cover Zepbound?

Nevada Medicaid does not cover Zepbound for weight loss. Nevada Medicaid plans include Anthem Blue Cross Blue Shield Healthy Blue, Health Plan of Nevada, Molina Healthcare of Nevada and SilverSummit Healthplan (Centene).

Nevada Medicaid (Nevada Check Up and the contracted MCOs) follows the standard weight-loss exclusion. Diabetes coverage with PA is standard.

The Nevada Medicaid drug list was last reviewed in the third quarter of 2025. Nevada Medicaid GLP-1 rules.

GLP-1 prescriptions Nevada Medicaid paid for

QuarterPrescriptionsMedicaid paidPer prescription
Apr to Jun 202516,852$18.3 million$1,080
Jul to Sep 202516,756$19.0 million$1,130
Oct to Dec 202516,257$18.7 million$1,150
Jan to Mar 202617,891$19.6 million$1,100

Nevada Medicaid paid for 17,891 GLP-1 prescriptions in the first quarter of 2026, up 6% from 16,852 in the second quarter of 2025.

Source: CMS State Drug Utilization Data, all GLP-1 brands, before rebates.

Obesity and insurance in Nevada

34.2% of adults in Nevada had obesity in 2024, by the CDC's state survey, against 33.1% for the US as a whole. 14.5% of Nevada residents have no health insurance and 12.2% live below the poverty line (Census SAIPE 2023). Of the largest counties, Nye County has the highest adult obesity rate, 39.7% (CDC PLACES 2025).

CountyAdults with obesityNo health insuranceBelow the poverty line
Clark County31.4%15.4%12.9%
Washoe County28.5%12.0%9.9%
Nye County39.7%13.1%15.4%
Lyon County35.2%12.4%9.6%
Carson City County33.1%12.9%10.4%
Elko County38.0%13.9%9.0%
Douglas County27.1%8.6%8.2%
Churchill County37.8%11.4%10.8%
Humboldt County36.2%14.0%10.4%
Pershing County35.7%15.0%16.8%

Source: CDC PLACES 2025 for obesity, Census SAIPE 2023 for insurance and poverty.

More for Nevada

Compounded tirzepatide is made by a licensed pharmacy to a prescription and is not FDA-approved. A prescriber decides whether it suits you.